November 25, 2023
1 min watch
Save
VIDEO: ‘Don’t taper’ TNF inhibitors for patients with RA in sustained remission
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
SAN DIEGO — Healio spoke with Kathryn Dao, MD, about a study assessing the effects of tapering to withdraw of TNF inhibitors compared with stable use among patients with rheumatoid arthritis.
Results from the multicenter randomized trial were presented at ACR Convergence 2023
“The message here is, don’t taper the medication,” said Dao, associate professor in the department of internal medicine’s division of rheumatology at UT Southwestern Medical Center.
Published by:
Sources/Disclosures
Collapse
Source:
Lillegraven S, et al. Abstract L07. Presented at: ACR Convergence 2023; Nov. 10-15, 2023; San Diego.
Disclosures:
Dao reports no relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.